Hemostasis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, "Hemostasis Global Clinical Trials Review, H1, 2013" provides data on the Hemostasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemostasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemostasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hemostasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Hemostasis 22
Subjects Recruited Over a Period of Time 23
Prominent Sponsors 24
Top Companies Participating in Hemostasis Therapeutics Clinical Trials 26
Prominent Drug Comparison 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Baxter International Inc. 29
Clinical Trial Overview of Baxter International Inc. 29
Novo Nordisk A/S 30
Clinical Trial Overview of Novo Nordisk A/S 30
ZymoGenetics, Inc. (Inactive) 31
Clinical Trial Overview of ZymoGenetics, Inc. (Inactive) 31
Ethicon Endo-Surgery, Inc. 32
Clinical Trial Overview of Ethicon Endo-Surgery, Inc. 32
Teva's Women's Health 33
Clinical Trial Overview of Teva's Women's Health 33
Omrix Biopharmaceuticals, Inc. 34
Clinical Trial Overview of Omrix Biopharmaceuticals, Inc. 34
Cardiochirurgia E.H. 35
Clinical Trial Overview of Cardiochirurgia E.H. 35
Nycomed GmbH 36
Clinical Trial Overview of Nycomed GmbH 36
Kantonsspital Aarau AG 37
Clinical Trial Overview of Kantonsspital Aarau AG 37
Children's Healthcare of Atlanta Inc. 38
Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 38
Aesculap AG 39
Clinical Trial Overview of Aesculap AG 39
Esbjerg Dentallaboratorium Aps 40
Clinical Trial Overview of Esbjerg Dentallaboratorium Aps 40
Takeda Pharmaceuticals International GmbH 41
Clinical Trial Overview of Takeda Pharmaceuticals International GmbH 41
Grifols, S.A. 42
Clinical Trial Overview of Grifols, S.A. 42
Vascular Solutions, Inc. 43
Clinical Trial Overview of Vascular Solutions, Inc. 43
Johnson & Johnson 44
Clinical Trial Overview of Johnson & Johnson 44
Bristol-Myers Squibb Company 45
Clinical Trial Overview of Bristol-Myers Squibb Company 45
Clinical Trial Overview of Top Universities / Institutes / Hospitals 46
Cardiovascular Institute & Fuwai Hospital 46
Clinical Trial Overview of Cardiovascular Institute & Fuwai Hospital 46
Rafsanjan University of Medical Sciences 47
Clinical Trial Overview of Rafsanjan University of Medical Sciences 47
Hospital del Mar 48
Clinical Trial Overview of Hospital del Mar 48
Academic Medical Centre 49
Clinical Trial Overview of Academic Medical Centre 49
University of Manitoba 50
Clinical Trial Overview of University of Manitoba 50
Karolinska Institutet 51
Clinical Trial Overview of Karolinska Institutet 51
The University of Hong Kong 52
Clinical Trial Overview of The University of Hong Kong 52
University of Illinois 53
Clinical Trial Overview of University of Illinois 53
Radboud University 54
Clinical Trial Overview of Radboud University 54
Five Key Clinical Profiles 55
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 76
List of Tables
List of Tables
Hemostasis Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Hemostasis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Hemostasis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Hemostasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 10
Hemostasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Hemostasis Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Hemostasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Hemostasis Global Clinical Trials Review, H1, 2013 published by GlobalData in January 25, 2013. This report consists of Pages: 76 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
